A detailed history of Financial Freedom, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Freedom, LLC holds 130 shares of BMY stock, worth $5,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130
Previous 129 0.78%
Holding current value
$5,198
Previous $6.61 Million 6.94%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $47 - $54
1 Added 0.78%
130 $7.07 Million
Q4 2023

Jan 24, 2024

BUY
$48.48 - $57.85 $48 - $57
1 Added 0.78%
129 $6.61 Million
Q3 2023

Nov 03, 2023

BUY
$57.89 - $64.73 $115 - $129
2 Added 1.59%
128 $7.4 Million
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $63 - $70
1 Added 0.8%
126 $8.08 Million
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $65 - $74
1 Added 0.81%
125 $8.69 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $8,491 - $10,055
124 New
124 $8.95 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Financial Freedom, LLC Portfolio

Follow Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Freedom, LLC with notifications on news.